Type 1 diabetes (T1D) impacts nearly two million Americans, and by the time most people learn they have it, most of the body's insulin-producing cells...
Vous n'êtes pas connecté
Maroc - Times of India - Life & Style - 13/12/2024 17:13
Researchers at Mount Sinai are developing a revolutionary pill using harmine, a DYRK1A inhibitor, to regenerate insulin-producing beta cells in the pancreas. Harmine alone tripled beta cell mass, and combined with a GLP-1 agonist like Ozempic, increased it by 700%. The team discovered that alpha cells could potentially be transformed into beta cells, offering a new source for insulin production.
Type 1 diabetes (T1D) impacts nearly two million Americans, and by the time most people learn they have it, most of the body's insulin-producing cells...
A small, early clinical trial led by the Icahn School of Medicine at Mount Sinai, USA, and collaborators has shown that directly injecting an...
A small, early clinical trial led by the Icahn School of Medicine at Mount Sinai, USA, and collaborators has shown that directly injecting an...
Highlights: FDA approves first oral GLP-1 agonist to lower heart attack and stroke risk in diabetics SOUL trial
Highlights: FDA approves first oral GLP-1 agonist to lower heart attack and stroke risk in diabetics SOUL trial
BAVINA SOOKDEO According to the International Diabetes Federation, presently, the prevalence of diabetes is between 12 to 15 per cent of our...
BAVINA SOOKDEO According to the International Diabetes Federation, presently, the prevalence of diabetes is between 12 to 15 per cent of our...
Scientists at Cedars-Sinai have discovered that old and damaged blood vessel cells may be an important cause of metabolic disorders like diabetes....
Scientists at Cedars-Sinai have discovered that old and damaged blood vessel cells may be an important cause of metabolic disorders like diabetes....
Each November, we observe National Diabetes Month and engage in discussions surrounding prevention, management and the impact of this increasingly...